HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$4.97
Day range
$4.71 - $5.00
Year range
$0.36 - $6.04
Market cap
394.49M USD
Avg Volume
541.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 16.79M | -75.94% |
Operating expense | 30.44M | -40.53% |
Net income | -85.70M | -236.29% |
Net profit margin | -510.44 | -1,298.08% |
Earnings per share | — | — |
EBITDA | -36.90M | -261.12% |
Effective tax rate | -116.21% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 278.60M | -14.66% |
Total assets | 354.78M | -27.72% |
Total liabilities | 503.03M | 22.27% |
Total equity | -148.25M | — |
Shares outstanding | 82.53M | — |
Price to book | -2.76 | — |
Return on assets | -22.65% | — |
Return on capital | -28.14% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -85.70M | -236.29% |
Cash from operations | -33.07M | 38.31% |
Cash from investing | -527.00K | -130.93% |
Cash from financing | 1.64M | 159.56% |
Net change in cash | -31.81M | 41.55% |
Free cash flow | -4.55M | 88.21% |
About
Founded
2011
Website
Employees
274